摘要 |
Compounds of formula 1 are effective modulators of PI3 kinase: wherein R<SUB>1 </SUB>is H, hydroxy, amino, lower alkyl, or trihalomethyl; R<SUB>2 </SUB>is amino, lower alkylamino, lower acylamino, arylamino, arylacyl-amino, heteroaryl-amino, heteroaryl-acyl amino, where aryl and heteroaryl are substituted with 0-3 substituents selected from the group consisting of halo, trihalomethyl, hydroxy, lower alkyl and lower alkoxy, or a substituent of the form -(CH<SUB>2</SUB>)<SUB>n</SUB>-C(-X)-R<SUB>8</SUB>, where n is 014 3 inclusive and X is O or NR<SUB>9</SUB>, where R<SUB>9 </SUB>is H, lower alkyl, or R<SUB>1 </SUB>and R<SUB>2 </SUB>together form -CH-N-X- where X is CH, NH, O, or S, and R<SUB>8 </SUB>is H, lower alkyl, lower alkoxy, aryl, aralkyl, or -(CH<SUB>2</SUB>)<SUB>m</SUB>CR<SUB>10</SUB>R<SUB>11</SUB>R<SUB>12</SUB>, where m is 0-3 inclusive, and R<SUB>10</SUB>, R<SUB>11</SUB>, and R<SUB>12 </SUB>are each independently H, lower alkyl, aryl, aralkyl, hydroxy, lower alkoxy, aryloxy, aralkoxy, amino, lower alkyl-amino, arylamino, aralkylamino, heteroaryl amino, or heteroaralkyl amino, where aryl and heteroaryl are substituted with 0-3 substituents selected from the group consisting of halo, hydroxy, and lower alkyl; R<SUB>3 </SUB>is H or lower alkyl; and R<SUB>4</SUB>, R<SUB>5</SUB>, R<SUB>6</SUB>, R<SUB>7 </SUB>are each independently H, halo, hydroxy, amino, nitro, lower alkyl, or lower alkoxy; and pharmaceutically acceptable salts thereof.
|